京東健康(06618.HK)披露「數智醫療」解決方案體系
內媒報道,京東健康(06618.HK)首席執行官金恩林於2022京東健康數智醫療大會上,展示「數智醫療」解決方案體系,包括技術開放平台、大數據應用體系、營運支持體系及供應鏈管理體系,同時通過一體化交付模式,為不同醫療服務機構提供全方位、定制化的數智醫療解決方案,將成為醫療服務體系高質量發展強有力的新引擎。
公司認為,數智醫療是一個能力體系,它覆蓋醫療服務體系的信息化全流程,是醫療服務在技術、模式、管理等方面,數碼化智慧化的綜合體現。
京東健康最新報57.45元,跌3.5%,成交186萬股,涉資1.07億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.